Raras
Buscar doenças, sintomas, genes...
Lipomatose encéfalo-cranio-cutânea
ORPHA:2396CID-10 · E88.2CID-11 · EF02.1OMIM 613001DOENÇA RARA

Uma doença rara que causa tumores, caracterizada pela presença de tumores de gordura (lipomas) apenas em um lado da cabeça, rosto e pescoço, e malformações no cérebro do mesmo lado.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença rara que causa tumores, caracterizada pela presença de tumores de gordura (lipomas) apenas em um lado da cabeça, rosto e pescoço, e malformações no cérebro do mesmo lado.

Publicações científicas
184 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
77
pacientes catalogados
Início
Antenatal
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E88.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
15 sintomas
❤️
Coração
10 sintomas
🦴
Ossos e articulações
9 sintomas
👁️
Olhos
7 sintomas
🧬
Pele e cabelo
5 sintomas
😀
Face
4 sintomas

+ 26 sintomas em outras categorias

Características mais comuns

100%prev.
HP:0001442
Frequência: 20/20
100%prev.
HP:0003577
Frequência: 5/5
100%prev.
Nevo psiloliparus
Frequência: 5/5
100%prev.
Alopecia
Muito frequente (99-80%)
90%prev.
Deficiência intelectual
Muito frequente (99-80%)
90%prev.
Lipomas múltiplos
Muito frequente (99-80%)
83sintomas
Muito frequente (11)
Frequente (35)
Ocasional (14)
Sem dados (23)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 83 características clínicas mais associadas, ordenadas por frequência.

HP:0001442
Frequência: 20/20100%
HP:0003577
Frequência: 5/5100%
Nevo psiloliparusNevus psiloliparus
Frequência: 5/5100%
Alopecia
Muito frequente (99-80%)100%
Deficiência intelectualIntellectual disability
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico184PubMed
Últimos 10 anos83publicações
Pico201611 papers
Linha do tempo
2026Hoje · 2026📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

KRASGTPase KRasCandidate gene tested inAltamente restrito
FUNÇÃO

Ras proteins bind GDP/GTP and possess intrinsic GTPase activity (PubMed:20949621, PubMed:39809765). Plays an important role in the regulation of cell proliferation (PubMed:22711838, PubMed:23698361). Activates MAPK1/MAPK3 resulting in phosphorylation and ultimately degradation of GJA1 (By similarity). Plays a role in promoting oncogenic events by inducing transcriptional silencing of tumor suppressor genes (TSGs) in colorectal cancer (CRC) cells in a ZNF304-dependent manner (PubMed:24623306)

LOCALIZAÇÃO

Cell membraneEndomembrane systemCytoplasm, cytosol

VIAS BIOLÓGICAS (2)
Signaling by moderate kinase activity BRAF mutantsRUNX3 regulates p14-ARF
MECANISMO DE DOENÇA

Leukemia, acute myelogenous

A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
30.7 TPM
Cérebro - Hemisfério cerebelar
25.1 TPM
Esôfago - Muscular
22.2 TPM
Esôfago - Mucosa
21.6 TPM
Esôfago - Junção
20.2 TPM
OUTRAS DOENÇAS (20)
gastric canceracute myeloid leukemialinear nevus sebaceous syndromeNoonan syndrome 3
HGNC:6407UniProt:P01116
FGFR1Fibroblast growth factor receptor 1Disease-causing somatic mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activati

LOCALIZAÇÃO

Cell membraneNucleusCytoplasm, cytosolCytoplasmic vesicle

VIAS BIOLÓGICAS (2)
Epithelial-Mesenchymal Transition (EMT) during gastrulationFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Pfeiffer syndrome

A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
144.8 TPM
Ovário
142.9 TPM
Artéria tibial
134.1 TPM
Fallopian Tube
122.3 TPM
Cérebro - Hemisfério cerebelar
122.0 TPM
OUTRAS DOENÇAS (20)
Hartsfield-Bixler-Demyer syndromeencephalocraniocutaneous lipomatosisosteoglophonic dysplasiaPfeiffer syndrome
HGNC:3688UniProt:P11362

Variantes genéticas (ClinVar)

666 variantes patogênicas registradas no ClinVar.

🧬 KRAS: GRCh38/hg38 12p13.33-11.1(chr12:64621-34650483)x3 ()
🧬 KRAS: NM_033360.4(KRAS):c.563T>A (p.Ile188Lys) ()
🧬 KRAS: GRCh38/hg38 12p13.33-q13.12(chr12:82453-49847230)x3 ()
🧬 KRAS: NM_004985.5(KRAS):c.204G>C (p.Arg68Ser) ()
🧬 KRAS: NM_004985.5(KRAS):c.59C>T (p.Thr20Met) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 154 variantes classificadas pelo ClinVar.

8
138
8
Patogênica (5.2%)
VUS (89.6%)
Benigna (5.2%)
VARIANTES MAIS SIGNIFICATIVAS
FGFR1: NM_023110.3(FGFR1):c.2156T>C (p.Met719Thr) [Likely pathogenic]
FGFR1: NM_023110.3(FGFR1):c.92-14C>A [Uncertain significance]
FGFR1: NM_023110.3(FGFR1):c.148C>T (p.Leu50=) [Uncertain significance]
FGFR1: NM_023110.3(FGFR1):c.176A>T (p.Asp59Val) [Uncertain significance]
FGFR1: NM_023110.3(FGFR1):c.622-20C>T [Uncertain significance]

Vias biológicas (Reactome)

49 vias biológicas associadas aos genes desta condição.

SOS-mediated signalling Activation of RAS in B cells Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants SHC1 events in ERBB2 signaling SHC1 events in ERBB4 signaling Signaling by SCF-KIT Signalling to RAS p38MAPK events GRB2 events in EGFR signaling SHC1 events in EGFR signaling Downstream signal transduction GRB2 events in ERBB2 signaling Tie2 Signaling EGFR Transactivation by Gastrin DAP12 signaling SHC-related events triggered by IGF1R FCERI mediated MAPK activation NCAM signaling for neurite out-growth Ca2+ pathway Ras activation upon Ca2+ influx through NMDA receptor VEGFR2 mediated cell proliferation CD209 (DC-SIGN) signaling Constitutive Signaling by EGFRvIII SHC-mediated cascade:FGFR1 FRS-mediated FGFR1 signaling SHC-mediated cascade:FGFR2 FRS-mediated FGFR2 signaling SHC-mediated cascade:FGFR3 FRS-mediated FGFR3 signaling FRS-mediated FGFR4 signaling PI3K Cascade PIP3 activates AKT signaling Signaling by FGFR1 amplification mutants Signaling by activated point mutants of FGFR1 FGFR1b ligand binding and activation FGFR1c ligand binding and activation FGFR1c and Klotho ligand binding and activation Constitutive Signaling by Aberrant PI3K in Cancer Signal transduction by L1 Phospholipase C-mediated cascade: FGFR1 Downstream signaling of activated FGFR1 PI-3K cascade:FGFR1 Negative regulation of FGFR1 signaling Signaling by FGFR1 in disease RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Signaling by plasma membrane FGFR1 fusions Epithelial-Mesenchymal Transition (EMT) during gastrulation Formation of paraxial mesoderm

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Lipomatose encéfalo-cranio-cutânea

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
79 papers (10 anos)
#1

A Case of Encephalocraniocutaneous Lipomatosis (ECCL) With Atypical Clinical Presentation Diagnosed on Molecular Testing: FGFR1 ECCL Tumor Risk.

American journal of medical genetics. Part A2026 Mar 19

Encephalocraniocutaneous lipomatosis (ECCL) is a neurocutaneous condition caused by postzygotic mosaic activating variants in genes including FGFR1, NRAS, or KRAS. It primarily affects the skin, eyes, and central nervous system. Diagnosis is typically based on characteristic clinical features and/or molecular confirmation. Here we report a unique case of ECCL in a 12-year-old female with abdominal wall lipoma, ipsilateral lower limb overgrowth, and brachydactyly, in whom somatic mosaicism for FGFR1 was identified using resected lipomatous tissue. Imaging studies confirmed additional spinal lipomas consistent with ECCL. This report expands the phenotypic spectrum of FGFR1-ECCL and underscores the importance of tissue-based somatic testing for diagnosis. Tumor risk is also discussed.

#2

Complex Epibulbar and Corneal Choristomas in Mosaic RASopathies.

Cornea2026 Feb 01

To describe the clinical features and management of ocular choristomas in mosaic RASopathy patients. We performed a retrospective single-center case review of all mosaic RASopathy patients. We evaluated for the presence of corneal and epibulbar choristomas and conducted a comprehensive analysis of the imaging, including operative microscope images, slitlamp images, and optical coherence tomography images. In doing so, we provide a precise description for these types of choristomas. Nine patients with mosaic RASopathies, 7 men and 2 women (3 with clinical diagnoses of Linear Sebaceous Nevus Syndrome, 5 with Oculoectodermal Syndrome, and 1 with Encephalocraniocutaneous Lipomatosis), were evaluated. Fourteen eyes with ocular choristomas were identified among the 9 patients-bilaterally in 5 and unilaterally in 4. Molecular confirmation was available in 6 cases, and pathogenic variants in the KRAS gene were identified in all 6. None of the choristomas presented as discrete raised lesions at the limbus alone; they were all relatively flat, very vascularized, and in 4 of the 14 eyes, there was involvement of the visual axis, with 6 having extension with vascularization onto the cornea. All of them extended into the conjunctiva and into the sclera posteriorly. Ocular choristomas with conjunctival and scleral extension, often with concomitant corneal vessels, should alert the clinician to the possibility of a mosaic RASopathy. Management can be complicated and includes measures such as optical iridectomy, anti-VEGF injections, and refractive correction with occlusion therapy, and corneal transplantation may also be considered.

#3

Encephalocraniocutaneous lipomatosis: a rare and sporadic phakomatosis.

Anais brasileiros de dermatologia2026
#4

Metachronous tumour (DNET and haemorrhagic chiasmal tumour) in a patient with encephalocraniocutaneous syndrome (ECCL).

BMJ case reports2025 Mar 31

Encephalocraniocutaneous lipomatosis (ECCL) is a rare neurocutaneous multisystem disorder affecting ectodermal and mesodermal tissues, including the eyes, skin, adipose tissue and the brain. It is hypothesised to be a neural crest disorder. While ECCL presents with various neurological features, the occurrence of brain tumour is an extremely rare association. Here, we report a case of metachronous tumours comprising a dysembryoplastic neuroepithelial tumour (DNET) and a haemorrhagic chiasmal tumour in a patient with ECCL. To the best of our knowledge, this is the first documented case of ECCL presenting with subarachnoid haemorrhage (SAH) in the suprasellar region due to a tumorous bleed. A woman in her mid-20s presented with a sudden onset headache and altered sensorium. Non-contrast CT of the brain showed a focal bleed in the suprasellar region with gyriform cortical calcification in the left temporoparietal lobe and left optic globe calcification. Digital subtraction angiography was inconclusive. MRI of the brain showed intracranial and intraspinal lipomas with changes suggestive of previous surgery in the left temporal lobe. A focal bleed was noticed in the optic chiasm and pial angiomas in the left temporoparietal lobe. The patient had a history of a left temporal arachnoid cyst and dysplastic left temporal lobe, for which she underwent a left temporal lobectomy to manage drug-refractory epilepsy. Histopathological examination of the resected tissue revealed a DNET with focal cortical dysplasia. The diagnosis of ECCL was established, with associated metachronous tumours identified at multiple locations in the brain. The presence of a metachronous tumour in a patient with ECCL is a rare occurrence. Hence, clinicians should maintain a high index of suspicion and ensure that such patients are monitored through long-term follow-up, with regular screening to facilitate the early detection of a second tumour.

#5

Haberland Syndrome (Encephalocraniocutaneous Lipomatosis): A Case Report and Review of Literature.

Iranian journal of child neurology2025

Encephalocraniocutaneous lipomatosis (ECCL), also known as Haberland syndrome, is a rare, nonhereditary, nonprogressive congenital neurocutaneous syndrome with underlying ectodermal dysgenesis. The classic triad of this syndrome is central nervous system (CNS), ocular, and cutaneous involvement as unilateral lipomatous lesions of the scalp, neck, and face with ipsilateral brain anomalies and ipsilateral ocular choristoma. Herein, this study reports a case of a 2-year-old boy presented with status epilepticus for the first time. Intraspinal lipoma, arachnoid cyst, cerebral hemiatrophy, asymmetric hydrocephaly, choristoma, and corneal clouding were noted. This case fulfilled Moog's clinical criteria for diagnosis of Haberland syndrome. Additionally, this study introduces linear and whorled nevoid hypermelanosis and cerebral periventricular white matter hyperintensity as novel manifestations of this syndrome.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC139 artigos no totalmostrando 81

2026

A Case of Encephalocraniocutaneous Lipomatosis (ECCL) With Atypical Clinical Presentation Diagnosed on Molecular Testing: FGFR1 ECCL Tumor Risk.

American journal of medical genetics. Part A
2026

Encephalocraniocutaneous lipomatosis: a rare and sporadic phakomatosis.

Anais brasileiros de dermatologia
2025

Histopathologic Features and Molecular Markers of Encephalocraniocutaneous Lipomatosis (ECCL).

Dermatopathology (Basel, Switzerland)
2026

Complex Epibulbar and Corneal Choristomas in Mosaic RASopathies.

Cornea
2025

Sturge-Weber Syndrome Without Cutaneous Stigmata Versus Encephalocraniocutaneous Lipomatosis Without Craniocutaneous Lipomatosis: A Case Report.

WMJ : official publication of the State Medical Society of Wisconsin
2025

A New Case Linking a Somatic NRAS Variant to Encephalocraniocutaneous Lipomatosis.

American journal of medical genetics. Part A
2025

Encephalocraniocutaneous lipomatosis-a neuroradiological perspective.

Pediatric radiology
2025

RASopathies. Part II: Cutaneous and extracutaneous manifestations.

Journal of the American Academy of Dermatology
2025

RASopathies. Part I: Genetics and therapeutic considerations.

Journal of the American Academy of Dermatology
2025

Functional hemispherectomy for seizure control in encephalocraniocutaneous lipomatosis: illustrative case.

Journal of neurosurgery. Case lessons
2025

Metachronous tumour (DNET and haemorrhagic chiasmal tumour) in a patient with encephalocraniocutaneous syndrome (ECCL).

BMJ case reports
2025

Encephalocraniocutaneous Lipomatosis - A Rare Neurophakomatoses.

Neurology India
2025

Haberland Syndrome (Encephalocraniocutaneous Lipomatosis): A Case Report and Review of Literature.

Iranian journal of child neurology
2025

Mosaic KRAS Mutation in Schimmelpenning-Feuerstein-Mims Syndrome With Overlapping Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis Features.

Pediatric dermatology
2024

Review of encephalocraniocutaneous lipomatosis.

Seminars in pediatric neurology
2024

A Hemorrhagic Brain Mass in a Child With Encephalocraniocutaneous Lipomatosis.

Journal of pediatric hematology/oncology
2024

Encephalocraniocutaneous lipomatosis phenotype associated with mosaic biallelic pathogenic variants in the NF1 gene.

Journal of medical genetics
2024

Encephalocraniocutaneous Lipomatosis: A Case Report.

Annals of plastic surgery
2024

Emerging insights into cephalic neural crest disorders: A single center experience.

Journal of clinical imaging science
2024

Haberland Syndrome (Encephalocraniocutaneous Lipomatosis) with Development of Diffuse Leptomeningeal Glioneural Tumor (DL-GNT) during Adolescence.

Clinical neuroradiology
2024

Calcified Sclero-Choroidal Choristomas in Mosaic RASopathies: A Description of a New Imaging Sign.

Ophthalmology. Retina
2024

Mosaic RASopathies concept: different skin lesions, same systemic manifestations?

Journal of medical genetics
2024

Navigating the complexities of encephalocraniocutaneous lipomatosis: a case series and review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2023

Teaching Neuroimage: A Rare Case of Encephalocraniocutaneous Lipomatosis: A Clinico-Radiological Diagnosis.

Neurology India
2024

Next generation sequencing aids diagnosis and management in a case of encephalocraniocutaneous lipomatosis.

Pediatric dermatology
2022

Encephalocraniocutaneous Lipomatosis: A Case Report and Literature Review.

Cureus
2022

Encephalocraniocutaneous Lipomatosis, a Radiological Challenge: Two Atypical Case Reports and Literature Review.

Brain sciences
2022

A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL.

Brain tumor pathology
2022

Toward clinical and molecular dissection of frontonasal dysplasia with facial skin polyps: From Pai syndrome to differential diagnosis through a series of 27 patients.

American journal of medical genetics. Part A
2022

Identification of Codon 146 KRAS Variants in Isolated Epidermal Nevus and Multiple Lesions in Oculoectodermal Syndrome: Confirmation of the Phenotypic Continuum of Mosaic RASopathies.

International journal of molecular sciences
2022

Expending the Phenotypic Spectrum of Encephalocraniocutaneous Lipomatosis: About a Prenatal Case With Complete Autopsy.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2021

Clinical and Neuroimaging Features of Encephalocraniocutaneous Lipomatosis.

Neurology
2023

Utility of Neonatal Findings in Early Diagnosis of a Case of Haberland Syndrome.

Journal of pediatric genetics
2021

Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.

American journal of medical genetics. Part A
2021

Ophthalmic Manifestation and Pathological Features in a Cohort of Patients With Linear Nevus Sebaceous Syndrome and Encephalocraniocutaneous Lipomatosis.

Frontiers in pediatrics
2021

Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome.

Frontiers in pediatrics
2021

Encephalocraniocutaneous lipomatosıs (Haberland syndrome) in a newborn baby: a case report with review of literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2021

Encephalocraniocutaneous Lipomatosis Associated with Orbital Cyst: A Variant or New Entity?

Turkish journal of ophthalmology
2020

Introduction to phacomatoses (neurocutaneous disorders) in childhood.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Fibrous Meningioma in a Patient with Encephalocraniocutaneous Lipomatosis: A Rare Case with Unique Features.

International medical case reports journal
2021

Haberland syndrome with bilateral ocular involvement.

Archivos de la Sociedad Espanola de Oftalmologia
2020

[Segmental overgrowth syndromes and therapeutic strategies].

Medecine sciences : M/S
2020

Encephalocraniocutaneous lipomatosis: A rare congenital neurocutaneous syndrome.

Radiology case reports
2020

Nevus psiloliparus: Newly described histopathological features from transverse sections.

Journal of cutaneous pathology
2020

Bilateral Alopecia in a Six-year-old Boy: A Quiz.

Acta dermato-venereologica
2019

Giant Ocular Lipodermoid Cyst in Encephalocraniocutaneous Lipomatosis: Surgical Treatment and Genetic Analysis.

The American journal of case reports
2020

Oculoectodermal Syndrome - Encephalocraniocutaneous Lipomatosis Associated with NRAS Mutation.

Acta dermato-venereologica
2019

Anaesthetic management of a case of Haberland's syndrome (encephalocraniocutaneous lipomatosis).

Indian journal of anaesthesia
2019

Sensitive detection of FGFR1 N546K mosaic mutation in patient with encephalocraniocutaneous lipomatosis and pilocytic astrocytoma.

American journal of medical genetics. Part A
2019

18F-Fludeoxyglucose Positron-emission Tomography/Computed Tomography in Encephalocraniocutaneous Lipomatosis/Haberland Syndrome.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
2019

Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.

Molecular genetics &amp; genomic medicine
2020

Up-regulation of fibroblast growth factor receptor 1 due to prenatal tobacco exposure can lead to developmental defects in new born.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2018

Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension.

American journal of medical genetics. Part A
2019

Eye and appearance characteristics of encephalocraniocutaneous lipomatosis.

Eye (London, England)
2018

Pseudodidymosis: nevus psiloliparus with aplasia cutis congenita, an initial manifestation of Haberland syndrome.

International journal of dermatology
2018

The impact of marine recreational fishing on key fish stocks in European waters.

PloS one
2018

Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas.

Acta neuropathologica
2018

Encephalocraniocutaneous Lipomatosis.

Journal of pediatric hematology/oncology
2017

Lipomatosis encefalocraneocutánea: reporte de caso.

Gaceta medica de Mexico
2017

Encephalocraniocutaneous Lipomatosis: Haberland Syndrome.

The American journal of case reports
2017

Encephalocraniocutaneous lipomatosis: A case report with review of literature.

The neuroradiology journal
2017

Encephalocraniocutaneous lipomatosis with Wilms' tumor.

Pediatrics international : official journal of the Japan Pediatric Society
2017

Partial Encephalocraniocutaneous Lipomatosis Syndrome.

Journal of pediatric neurosciences
2016

Short stature and growth hormone deficiency in a girl with encephalocraniocutaneous lipomatosis and Jaffe-Campanacci syndrome: a case report.

Annals of pediatric endocrinology &amp; metabolism
2016

A rare case of dysembryoplastic neuroepithelial tumor combined with encephalocraniocutaneous lipomatosis and intractable seizures.

Korean journal of pediatrics
2016

Encephalocraniocutaneous lipomatosis (Haberland syndrome): A rare case report.

Indian dermatology online journal
2016

Tip of an Iceberg: Skull Fracture as an Adult Presentation of Encephalocraniocutaneous Lipomatosis.

Case reports in neurological medicine
2016

Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: A case report.

Molecular and clinical oncology
2016

Encephalocraniocutaneous lipomatosis (Fishman syndrome): A rare neurocutaneous syndrome.

Journal of current ophthalmology
2018

Haberland syndrome: Clinical and neuroimaging findings leading to diagnosis.

Neurologia
2016

Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement.

JAAD case reports
2016

Encephalocraniocutaneous Lipomatosis Without Ocular Malformations.

Pediatric neurology
2016

Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis.

Clinical genetics
2016

Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.

American journal of human genetics
2015

Mosaic Neurocutaneous Disorders and Their Causes.

Seminars in pediatric neurology
2015

Neuroimaging Findings in Encephalocraniocutaneous Lipomatosis.

Pediatric neurology
2016

Encephalocraniocutaneous lipomatosis, a rare neurocutaneous disorder: report of additional three cases.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2015

Ossifying Fibroma in a Patient With Oculocerebrocutaneous (Delleman) Syndrome.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
2015

Characteristic imaging findings in encephalocraniocutaneous lipomatosis.

Neurology
2015

Grade II pilocytic astrocytoma in a 3-month-old patient with encephalocraniocutaneous lipomatosis (ECCL): case report and literature review of low grade gliomas in ECCL.

American journal of medical genetics. Part A
2015

Encephalocraniocutaneous Lipomatosis: A Rare Association With Tethered Spinal Cord Syndrome With Review of Literature.

Child neurology open
Ver todos os 139 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Lipomatose encéfalo-cranio-cutânea.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Lipomatose encéfalo-cranio-cutânea

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A Case of Encephalocraniocutaneous Lipomatosis (ECCL) With Atypical Clinical Presentation Diagnosed on Molecular Testing: FGFR1 ECCL Tumor Risk.
    American journal of medical genetics. Part A· 2026· PMID 41856681mais citado
  2. Complex Epibulbar and Corneal Choristomas in Mosaic RASopathies.
    Cornea· 2026· PMID 41198137mais citado
  3. Encephalocraniocutaneous lipomatosis: a rare and sporadic phakomatosis.
    Anais brasileiros de dermatologia· 2026· PMID 41558425mais citado
  4. Metachronous tumour (DNET and haemorrhagic chiasmal tumour) in a patient with encephalocraniocutaneous syndrome (ECCL).
    BMJ case reports· 2025· PMID 40164482mais citado
  5. Haberland Syndrome (Encephalocraniocutaneous Lipomatosis): A Case Report and Review of Literature.
    Iranian journal of child neurology· 2025· PMID 39896701mais citado
  6. A 2-month-old infant with an alopecic plaque.
    JAAD Case Rep· 2026· PMID 41909240recente
  7. Histopathologic Features and Molecular Markers of Encephalocraniocutaneous Lipomatosis (ECCL).
    Dermatopathology (Basel)· 2025· PMID 41283481recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2396(Orphanet)
  2. OMIM OMIM:613001(OMIM)
  3. MONDO:0013074(MONDO)
  4. GARD:2108(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q17540092(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Lipomatose encéfalo-cranio-cutânea
Compêndio · Raras BR

Lipomatose encéfalo-cranio-cutânea

ORPHA:2396 · MONDO:0013074
Prevalência
<1 / 1 000 000
Casos
77 casos conhecidos
Herança
Not applicable
CID-10
E88.2 · Lipomatose não classificada em outra parte
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0406612
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades